Can tenofovir alafenamide fumarate tablets/Veride be taken to prepare for pregnancy?

Tenofovir alafenamide/viride (TAF) is used to treat chronic hepatitis B infection, a viral infection of the liver. It works by stopping or slowing the growth of viruses. Chronic hepatitis infection can lead to severe liver damage (cirrhosis) and liver cancer. It is not known whether tenofovir alafenamide can cure hepatitis B or prevent patients from transmitting the virus to others. Practice "safer sex" (such as using latex condoms) to reduce the risk of passing the virus to others.

When considering the use of any medication, especially in patients trying to become pregnant, it is important to weigh the benefits and risks of the medication. The safety and effectiveness of tenofovir alafenamide fumarate tablets have not been fully studied and confirmed in pregnant women. Therefore, the necessity of using tenofovir alafenamide fumarate tablets needs to be carefully weighed for patients who are preparing to become pregnant. If a patient has been diagnosed with HBV infection and is being treated, the doctor may recommend continuing to use tenofovir alafenamide to control the condition, because untreated HBV infection may have a negative impact on fetal health. However, in this case, your doctor may adjust your dose or monitor your condition and conduct periodic evaluations and consultations.

On the other hand, if a patient has not started taking tenofovir alafenamide and plans to become pregnant, the doctor may recommend delaying treatment until the end of the pregnancy. This is because the safety of tenofovir alafenamide fumarate tablets has not been fully confirmed during pregnancy, so in order to avoid potential adverse effects on the fetus, temporarily discontinuing the use of the drug may be a more appropriate option.